Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease [9]

Gut

Volumn 55, Issue 10, 2006, Pages 1527-1528

  Kakuta, Y ^a   Kinouchi, Y ^a   Negoro, K ^a   Takahashi, S ^a   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TNFSF15; STEROID; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALLELE; CONTROLLED STUDY; ENTERITIS; GENETIC ASSOCIATION; HUMAN; INTESTINE SURGERY; LETTER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HUMANS; INFLAMMATORY BOWEL DISEASES; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 33749182955     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.100297     Document Type: Letter

References (6)

1. Migone TS, Zhang J, Luo X, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002;16:479-92.
2. Bamias G, Martin C iii, Marini M, et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol 2003;171:4868-74.
3. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005;14:3499-506.
4. Heinemeyer T, Wingender E, Reuter I, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998;26:362-7.
5. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-96.
6. Ferber IA, Lee HJ, Zonin F, et al. GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels. Clin Immunol 1999;91:134-44.